IONS•benzinga•
Redburn Atlantic Initiates Coverage On Ionis Pharmaceuticals with Neutral Rating, Announces Price Target of $39
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 31, 2025 by benzinga